Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-08 Sale | 2023-06-12 6:23 pm | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 3,750 | $20.85 | $78,188 | 50,487 (Direct) | View |
| 2023-06-01 Sale | 2023-06-06 7:23 pm | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 2,247 | $18.31 | $41,143 | 20,112 (Direct) | View |
| 2023-05-09 Purchase | 2023-05-11 5:50 pm | 4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Parent GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 850,000 | $16 | $13,600,000 | 4,787,914 (Indirect) | View |
| 2023-04-21 Sale | 2023-04-25 6:44 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 3,750 | $20 | $75,000 | 54,609 (Direct) | View |
| 2023-04-21 Sale | 2023-04-25 6:43 pm | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 5,000 | $20.05 | $100,270 | 32,500 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 6:16 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 2,248 | $19.3 | $43,386 | 22,359 (Direct) | View |
| 2023-02-21 Sale | 2023-02-23 7:56 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 34,446 | $20.61 | $709,873 | 1,859,153 (Direct) | View |
| 2023-01-19 Sale | 2023-01-23 7:57 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 19,524 | $20.1 | $392,474 | 1,893,599 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 5:56 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer 10% Owner | 86,877 | $23.23 | $2,018,344 | 1,913,123 (Direct) | View |
| 2022-12-01 Sale | 2022-12-05 5:33 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 6,000 | $22.79 | $136,725 | 80,857 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-01 Option Award | 2023-10-03 4:17 pm | N/A 2033-09-30 | 4D Molecular Therapeutics Inc. | FMDT | Mehra Uneek See Remarks | 229,634 | $0 | 229,634 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-12 6:23 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 3,750 | $0 | 50,487 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-12 6:23 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 3,750 | $8.04 | 50,487 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-06 7:23 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 1,875 | $6.49 | 20,112 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-06 7:23 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FMDT | Bizily Scott Chief Legal and HR Officer | 1,875 | $0 | 20,112 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:42 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | MILLIGAN JOHN F Director | 33,750 | $0 | 33,750 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:39 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | Tomasello Shawn Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:37 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | Miller-Rich Nancy Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:35 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:33 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | GRAY SUSANNAH Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:32 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | Chacko Jacob Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:31 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | Kasahara Noriyuki Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-16 8:52 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FMDT | Moretti August J Chief Financial Officer | 3,000 | $9.41 | 228,105 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-16 8:52 pm | N/A 2029-03-19 | 4D Molecular Therapeutics Inc. | FMDT | Moretti August J Chief Financial Officer | 3,000 | $0 | 228,105 (Direct) | View |
| 2023-05-02 Gift | 2023-05-04 8:09 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 600,000 | $0 | 1,859,153 (Direct) | View |
| 2023-04-21 Exercise | 2023-04-25 6:44 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 3,750 | $0 | 54,609 (Direct) | View |
| 2023-04-21 Exercise | 2023-04-25 6:44 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 3,750 | $8.04 | 54,609 (Direct) | View |
| 2023-04-21 Exercise | 2023-04-25 6:43 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 5,000 | $9.41 | 32,500 (Direct) | View |
| 2023-04-21 Exercise | 2023-04-25 6:43 pm | N/A 2029-03-19 | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 5,000 | $0 | 32,500 (Direct) | View |
Ownership | 2023-04-05 9:28 pm | N/A 2030-11-08 | 4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer | 0 | $0 | 320,000 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 6:16 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 1,875 | $6.49 | 22,359 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 6:16 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 1,875 | $0 | 22,359 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 8:26 pm | N/A 2033-02-09 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 8:24 pm | N/A 2033-02-09 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 222,000 | $0 | 222,000 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 8:23 pm | N/A 2033-02-09 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz President & COO | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 8:23 pm | N/A 2033-02-09 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-22 6:51 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J Chief Financial Officer | 3,000 | $9.41 | 226,655 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-22 6:51 pm | N/A 2029-03-19 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J Chief Financial Officer | 3,000 | $0 | 226,655 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-05 5:33 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 1,875 | $6.49 | 80,857 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-05 5:33 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 5,625 | $0 | 80,857 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-05 5:33 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 3,750 | $8.04 | 80,857 (Direct) | View |
| 2022-09-23 Option Award | 2022-09-27 5:08 pm | N/A 2032-09-22 | 4D Molecular Therapeutics Inc. | FDMT | Kasahara Noriyuki Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-09-23 Option Award | 2022-09-27 5:05 pm | N/A 2032-09-22 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz President & COO | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 8:42 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | FISHMAN ROBERT S Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 8:41 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | Moretti August J Chief Financial Officer | 60,000 | $0 | 62,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 8:40 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 8:38 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 60,000 | $0 | 60,000 (Direct) | View |
Ownership | 2022-06-27 5:38 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 3,912,984 (Direct) | View |
| 2022-06-18 Option Award | 2022-06-21 7:54 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:08 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | Tomasello Shawn Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:06 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:05 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director | 33,750 | $0 | 33,750 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:02 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director | 22,500 | $0 | 22,500 (Direct) | View |